Mukozal

Mukozal is a brand name for a medication containing the active ingredient moclobemide. Moclobemide is a reversible inhibitor of monoamine oxidase A (RIMA). Monoamine oxidase A is an enzyme involved in the breakdown of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. By inhibiting this enzyme, moclobemide increases the levels of these neurotransmitters, which are thought to play a role in mood regulation.

Mukozal is primarily prescribed for the treatment of depressive episodes, including those associated with anxiety disorders. It is generally considered to have a more favorable side effect profile and fewer dietary restrictions compared to older, irreversible monoamine oxidase inhibitors. However, potential side effects can include dizziness, nausea, insomnia, and headache.

The dosage and duration of treatment with Mukozal are determined by a healthcare professional based on the individual patient's condition and response. It is important to follow the prescribed dosage instructions carefully. Like all medications, Mukozal may interact with other drugs, and patients should inform their doctor about any other medications they are taking. The use of Mukozal is contraindicated in individuals with certain medical conditions, such as severe liver or kidney impairment, and in those taking specific other medications.